Morgan Stanley Issues Positive Forecast for Solventum (NYSE:SOLV) Stock Price

Solventum (NYSE:SOLV) had its target price increased by Morgan Stanley from $73.00 to $80.00 in a research report released on Wednesday morning,Benzinga reports. The firm currently has an equal weight rating on the stock.

Several other brokerages also recently commented on SOLV. Piper Sandler raised their target price on Solventum from $75.00 to $84.00 and gave the stock a “neutral” rating in a research note on Friday, February 28th. The Goldman Sachs Group raised their target price on Solventum from $63.00 to $71.00 and gave the stock a “sell” rating in a research note on Monday. Mizuho raised their target price on Solventum from $70.00 to $82.00 and gave the stock a “neutral” rating in a research note on Monday. Wells Fargo & Company raised their target price on Solventum from $73.00 to $75.00 and gave the stock an “equal weight” rating in a research note on Friday, February 28th. Finally, Bank of America raised their price target on Solventum from $80.00 to $85.00 and gave the company a “neutral” rating in a report on Wednesday, February 26th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $79.86.

Solventum Stock Down 1.5 %

SOLV stock opened at $77.79 on Wednesday. Solventum has a fifty-two week low of $47.16 and a fifty-two week high of $85.92. The stock has a fifty day moving average of $73.25 and a 200-day moving average of $70.39. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. The company has a market capitalization of $13.44 billion and a price-to-earnings ratio of 28.29.

Hedge Funds Weigh In On Solventum

A number of large investors have recently modified their holdings of SOLV. Modus Advisors LLC purchased a new position in shares of Solventum during the 4th quarter valued at about $25,000. Clarity Asset Management Inc. purchased a new position in shares of Solventum during the 4th quarter valued at about $25,000. Stonebridge Financial Group LLC purchased a new position in shares of Solventum during the 4th quarter valued at about $26,000. Raiffeisen Bank International AG purchased a new position in shares of Solventum during the 4th quarter valued at about $29,000. Finally, Crews Bank & Trust purchased a new stake in shares of Solventum in the fourth quarter worth $32,000.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.